Nektar Therapeutics
USPTO PatentsView assignee record - 196 granted patents across 27 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Nektar ranks #2,030 of 49,997 tracked US assignees by granted-patent volume, with 196 patents across 27 technology areas.
- #2,030
- of 49,997 US assignees by volume
- Top 19%
- by Innovation Score (47.1/100)
- 12.5
- avg claims per patent
- -67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R2030 · US Corporation #2,030 · 196 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MID 196 grants
- TOP-DECILE #2,030/49,997
- PHOTO-FINISH Biomet Sports Medicine
- CPC-FOCUS A61K · 27 areas
- INNOV-PAR 47.1/100
- CLAIMS-RICH 12.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Biomet Sports Medicine, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Nektar’s 47.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Nektar
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Aten International · near
Aten International · near
47 score
- Dreamworks Animation · near
Dreamworks Animation · near
47 score
- Intrabio · near
Intrabio · near
47 score
- MVE Biological… · near
MVE Biological… · near
47 score
- Nektar Therapeutics · this assignee
Nektar Therapeutics · this assignee
47 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Nektar's Innovation Score is 47.1/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Nektar?
Each dot is one of Nektar’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nektar’s own 12.5 claims/patent is at or below the 13.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Nektar's grants concentrate
Nektar Therapeutics is a focused PatentsView assignee: 27 CPC subclasses with 89.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (41 grants) versus a trough of 5 in 2024. By volume, Nektar sits between Sorin CRM SAS and China Mobile Communications Group Co., Ltd..
Nektar's three-year grant acceleration
From 2019–2021 to 2022–2024, Nektar Therapeutics moved from 45 to 20 grants (0.44x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,804. See the growth leaderboard.
Who files at Nektar's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Sorin CRM SAS
Sorin CRM SAS
197 patents
- Securus
Securus Technologies, LLC
197 patents
- Timotion Technolo…
Timotion Technology Co., Ltd.
197 patents
- Biomet Sports Med…
Biomet Sports Medicine, LLC
196 patents
- Olympus Winter &…
Olympus Winter & IBE GMBH
196 patents
- Specialized Bicyc…
Specialized Bicycle Components, Inc.
196 patents
- True Velocity IP…
True Velocity IP Holdings, Inc.
196 patents
- Nektar Therapeuti… ◀
Nektar Therapeutics
196 patents
- China Mobile Comm…
China Mobile Communications Group Co., Ltd.
195 patents
What this shows Nektar holds 196 patents at rank #2,030, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Nektar
By rank, the assignees closest to #2,030 in granted patent volume.
- Sorin CRM SAS #2,026 · 197 patents
- Securus Technologies, LLC #2,027 · 197 patents
- Timotion Technology Co., Ltd. #2,028 · 197 patents
- Biomet Sports Medicine, LLC #2,029 · 196 patents
- Olympus Winter & IBE GMBH #2,031 · 196 patents
- Specialized Bicycle Components, Inc. #2,032 · 196 patents
- True Velocity IP Holdings, Inc. #2,033 · 196 patents
- China Mobile Communications Group Co., Ltd. #2,034 · 195 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Nektar's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Nektar, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Nektar ranks #98 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (47 here).
Similar claim depth
Nearest assignees by average claims per patent (12.5 here).
Nektar's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 41 | 20.9% |
| 2016 | 39 | 19.9% |
| 2017 | 27 | 13.8% |
| 2018 | 19 | 9.7% |
| 2019 | 18 | 9.2% |
| 2020 | 15 | 7.7% |
| 2021 | 12 | 6.1% |
| 2022 | 8 | 4.1% |
| 2023 | 7 | 3.6% |
| 2024 | 5 | 2.6% |
| 2025partial year | 5 | 2.6% |
Which technologies does Nektar Therapeutics patent most?
Top 15 of 27 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Nektar Therapeutics's patent record in context - here's where to go next.
- Nektar Therapeutics's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 89.3% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #2,030 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Nektar Therapeutics against Sorin CRM SAS, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 47.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.